India has edge in COVID-19 vaccines, global study says

India has three potential coronavirus candidates in race with global contendors rushing to clear trials. A new global analysis of advance market commitments (AMCs) for experimental vaccines observed that India has an edge in the global vaccine race. The report, as quoted by the Hindustan Times, said that India has used its manufacturing capability to pre-order 600 million doses of the vaccine and is negotiating for another billion doses, which is enough to vaccinate at least half the population. India is only second to the US, which has pre-ordered 810 million and another 1.6 billion doses under negotiation. 

from IndiaTV India: Google News Feed https://ift.tt/2TGG6MV
via